Antifungal susceptibility profile of human-pathogenic species of Lichtheimia.

Alastruey-Izquierdo A, Cuesta I, Walther G, Cuenca-Estrella M, Rodriguez-Tudela JL (2010) Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrob Agents Chemother 54(7), 3058-3060.

Abstract

Forty-four isolates belonging to human pathogenic species of Lichtheimia were tested against nine antifungal agents by using the EUCAST methodology. No remarkable differences were found between the clinical species, although L. ramosa showed slightly higher MICs for all drugs. Amphotericin B was the most active drug. Among azole drugs, posaconazole had the best activity in vitro and voriconazole was inactive. Echinocandins showed activity for some isolates, suggesting a potential role in combination therapy.

Leibniz-HKI-Autor*innen

Grit Walther

Identifier

doi: 10.1128/AAC.01270-09

PMID: 20421405